Navigation Links
PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022
Date:9/18/2013

London (PRWEB) September 18, 2013

Summary

Respiratory syncytial virus (RSV) is a common cause of pediatric respiratory infections and virtually all children will have been infected by the virus by the age of two. RSV transmission typically occurs during the winter and early spring months. The virus is spread through the air by an infected person’s sneeze or cough, or through direct and indirect contact with nasal secretions of an infected person. The majority of RSV infections present as mild upper respiratory illnesses that often self-resolve within two weeks, but about 1% of the cases develop serious lower respiratory complications requiring hospitalization. Children under the age of two with certain health conditions are most at risk for severe RSV infections and are therefore recommended to receive RSV prophylaxis treatments. The only FDA-approved prophylactic intervention in the US is AstraZeneca’s Synagis (palivizumab), a humanized monoclonal antibody against the fusion protein of the virus.

Highlights

Key Questions Answered

  • What are the treatment algorithms and what do most pediatricians and neonatologists adhere to?
  • What unmet needs still remain and what do key opinion leaders think?
  • How likely is it that Synagis’ biosimilars will enter the market during the forecast period?
  • What promising interventions are in the pipeline for this narrow patient segment?
  • What are the likely changes in future guidelines as expected by key opinion leaders?

Key Findings

  • The majority of physicians adhere to the AAP guidelines limiting the number of doses and narrowing the use of Synagis
  • AstraZeneca, with Synagis, will continue its stronghold of the RSV market for the forecast period
  • Pipeline prophylactic indications will be first in class (active/maternal i
    '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
2. MR enterography is as good or better than standard imaging exams for pediatric Crohns patients
3. Use of dedicated pediatric imaging departments for pediatric CT reduces radiation dose
4. Dr. Yael Mosse will receive first Nachman Award in Pediatric Oncology at national conference
5. Ben-Gurion U. and Cincinnati Childrens Hospital to develop pediatric-specific medical technologies
6. Many Parents of Kids With Autism Dont Put Faith in Pediatricians
7. Pediatric epilepsy impacts sleep for the child and parents
8. Tiny Tots in the Dentists Chair Among Changes in Pediatric Dentistry
9. Pediatric kidney expert receives Young Investigator Award from American Transplant Congress
10. Pediatric regime of chemotherapy proves more effective for young adults
11. Progress in quest to reduce use of radiation in treatment of pediatric Hodgkin lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... could lead to potential new treatments for breaking the ... , Fibrosis, or scarring, is a hallmark of the ... can lead to serious organ damage and, in some ... centers on findings made by Swati Bhattacharyya, PhD, research ... a specific protein plays in promoting fibrosis. , ...
(Date:4/17/2014)... relief targets that could be used to provide ... College London made the discovery when researching how ... the body. , Dr Marzia Malcangio said: "We ... generation and our findings could help chemotherapy patients ... potential side effect of some chemotherapy drugs (such ...
(Date:4/17/2014)... the University of California, San Diego School of Medicine ... have suffered a recent major loss are more likely ... , The study is published in this month,s issue ... , Because compassionate behaviors are associated with better health ... insights into ways to improve the outcomes of individuals ...
(Date:4/17/2014)... University synthetic biology team has created a new ... therapeutics that could travel the body and selectively ... Engineering cell-based, biological devices that monitor and modify ... synthetic biology. However, no existing technology enabled bioengineers ... physiological state and respond in a customized fashion. ...
(Date:4/17/2014)... cause of neuronal death in Parkinson,s disease is still ... be mistaken for foreign invaders and killed by the ... diseases like type I diabetes, celiac disease, and multiple ... April 16, 2014, in Nature Communications . , ... Parkinson,s disease; but if true, it could lead to ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2
... Association (NMA), the nation,s premier membership organization for ... amount of $120,000 from the W.K. Kellogg Foundation. ... grant commitment, designed "to promote health care coverage ... partner organizations."Partner organizations for this effort include Families ...
... in urban areas , , TUESDAY, April 21 (HealthDay News) -- ... areas are not less likely to get a kidney transplant ... , Researchers analyzed U.S. data on 699,751 adults with kidney ... 1995 and 2007. After about two years on the list, ...
... reduced risk of relapse or death, study finds , , ... lymphoma who drank wine before their diagnosis appeared to ... to a study that,s the first to identify this ... women with non-Hodgkin lymphoma and found that, overall, those ...
... your memory will get worse as you get older may ... University have found that senior citizens who think older people ... worse than seniors who do not buy in to negative ... published earlier this month, psychology professor Dr. Tom Hess and ...
... April 21 DaVita Inc. (NYSE: ... services for those diagnosed with chronic kidney disease ... as the company,s Senior Vice President of Federal ... public policy efforts in Washington, D.C. and report ...
... quality care needs in skilled nursing facilitiesCOLUMBUS, Ohio, ... Nursing Care Coalition, the umbrella group representing Ohio,s ... of the state budget bill unveiled by House ... services to Ohio,s frail elderly and disabled citizens ...
Cached Medicine News:Health News:National Medical Association Receives Funding From Kellogg for Training Community Advocates 2Health News:Distance No Bar to Kidney Transplants in Remote Areas 2Health News:Wine May Guard Against Lymphoma Recurrence 2Health News:Think memory worsens with age? Then yours probably will 2Health News:John Schaeffler Appointed Senior Vice President for Federal Legislative Affairs 2Health News:Skilled Nursing Care Coalition Praises House Leadership for Budget Changes 2
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
Finesse II electrosurgical generator (100-120 VAC) utilizes a patented design that integrates the electrosurgical generator and smoke evacuation system into a single compact unit....
... 950, the first High Frequency Desiccator with Cut. ... half of the unit is a high frequency ... popular Aaron 900. The other half is a ... power and coag capabilities plenty of power ...
Medicine Products: